Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and ...

Overweight or obese type 1 diabetics taking Mounjaro were able to reduce the amount of daily insulin they needed, researchers ...

A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced ...

Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs ...

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) ...

A new prescription drug in the battle against obesity has this week been approved by Australian regulators, with experts ...

Ozempic and Wegovy are branded versions of semaglutide made by pharmaceutical company Novo Nordisk. Ozempic has been ...

Results from 4 studies revealed that women lost more weight on average than men when taking tirzepatide — but they also ...

Although women lost more weight, all participants saw significant decreases in total body weight on all doses of the medication.

Women tend to lose more weight than men when on the weight loss jab Mounjaro, according to analysis. Mounjaro – also known as ...

Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterparts—but also experienced more nausea and ...

Eli Lilly and Company has appointed Lucas Montarce as executive vice president and chief financial officer, effective ...